Acquisition of Treasury Shares
First written in FY2019. 1 of 7 entries say "Advanced", first in FY2021-Q2. Latest entry: FY2027-H1.
- FY2027-H1Recognition of expenditure on the acquisition of treasury sharesAnnual report
「Expenditures for the acquisition of treasury shares △92」
The company recorded expenditures of ¥92 thousand for the acquisition of treasury shares during the interim consolidated accounting period. - FY2025Cancellation of 300,000 Treasury SharesAnnual report
「At a meeting of the Board of Directors held on 4 April 2025, the Company resolved, pursuant to Article 178 of the Companies Act, to cancel treasury shares, and carried out the cancellation on 30 April 2025.」
The Company cancelled 300,000 treasury shares on 30 April 2025. As of the filing date, shares issued totaled 3,770,000 and treasury shares totaled 8,273. - FY2025-H1Decrease in treasury sharesAnnual report
「Medical Ikkou Group Co.,Ltd. 308,200 ─ 308,200 7.57」
As of 31 August 2024, treasury shares totaled 308,200 shares, representing 7.57% of total shares issued. The balance decreased from the 312,973 shares reported for the previous full fiscal year. - FY2023Disposal of treasury shares as restricted stock compensationAnnual report
「Other (disposal of treasury shares as restricted stock compensation) 1,000 1,724」
During the fiscal year, the Company disposed of 1,000 treasury shares as restricted stock compensation, leaving a treasury share balance of 312,973 shares. - FY2021-Q3Increase in treasury sharesAnnual report
「Total net assets amounted to ¥10,286 million, an increase of ¥115 million from the end of the previous consolidated fiscal year. This was mainly attributable to a ¥526 million increase in retained earnings, partly offset by a ¥261 million increase in treasury shares and a ¥158 million decrease in the valuation difference on other securities.」
Treasury shares increased by ¥261 million from the end of the previous consolidated fiscal year. - FY2021-Q2AdvancedAnnual report
「Expenditure on the acquisition of treasury shares: ¥271.92 million」
The Company acquired treasury shares during the six-month period ended 30 September, with expenditure on the acquisition totaling ¥271.92 million. - FY2019First statedAnnual report
「Status of the resolution at the Board of Directors meeting (21 November 2018) (acquisition period: 22 November 2018 to 22 November 2018): 15,000 shares, ¥122.25 million. Treasury shares acquired during the fiscal year: 9,900 shares, ¥80.685 million.」
The Company reported for the first time that it acquired 9,900 treasury shares for ¥80.685 million during the fiscal year pursuant to a resolution of the Board of Directors.